Clinical Trial Update: Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating senolytics to slow progression of sepsis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Senolytics

Snippet

Sponsor: University of Minnesota | Conditions: Sepsis, Acute Infection | Phase 2 | Status: RECRUITING